Stay updated on Upadacitinib vs Placebo in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA Clinical Trial page
- Check4 days agoChange DetectedAdded Rheumatoid arthritis and MedlinePlus Genetics as related topics, and updated the revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check11 days agoChange DetectedDeleted the 'Rheumatoid arthritis' topic tag and the related topics section, including 'MedlinePlus Genetics'.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedAdded related topics tags 'Rheumatoid arthritis' and 'MedlinePlus Genetics' to the page's topics section. This metadata enhancement aids indexing and discoverability without changing the study details or core content.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page now shows Revision: v3.4.2, and the government-funding lapse notice along with the Revision: v3.4.1 entry have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check40 days agoChange DetectedAdded a site-wide government funding notice and updated the site revision to v3.4.1, and removed related topics (Rheumatoid arthritis) and the older revision tag (v3.4.0); to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check47 days agoChange DetectedUI updates include showing the glossary, updating the QC update label to 'Last Update Submitted that Met QC Criteria', and revising No FEAR Act text with a version bump from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Placebo in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.